Théa Introduces iVIZIA™ OTC Eye-Care Products in US

Thea Pharma Inc. (“Théa”), the US subsidiary of Europe’s leading independent pharmaceutical company specializing in the research, development, and commercialization of eye-care products, announced the availability of the iVIZIA line of over-the-counter (OTC) eye-care products in the United States. The iVIZIA OTC product line includes lubricating eye drops, lubricating eye hygiene gel, and three options … Read more

Théa Completes its Acquisition of Akorn’s Branded Ophthalmic

Thea Pharma Inc. (“Théa”), the US subsidiary of Europe’s leading independent pharmaceutical company specializing in the research, development, and commercialization of eye care products, announced the completion of its previously announced acquisition of seven branded ophthalmic products from Akorn Operating Company LLC. The transactions expands Théa’s role as an important provider of products designed to … Read more

Théa to Acquire Branded Ophthalmic Products from Akorn

Laboratoires Théa SAS (“Théa”), Europe’s leading independent pharmaceutical company specializing in the research, development, and commercialization of eye-care products, announced an agreement to purchase seven branded ophthalmic products from Akorn Operating Company LLC. The transaction will make Théa a best-in-class provider of products designed to fill the needs of eye-care professionals across the United States. … Read more